Learning outcomes
By the end of this lesson you should be able to: define a drug and distinguish it from a placebo, a poison and a general anaesthetic; state what a receptor is and name the four receptor families; explain the principle that the receptor determines the response and the drug only triggers it; describe how a drug's site of action gives rise to its therapeutic and toxic effects; and predict from a receptor's tissue distribution which side effects a drug would be expected to produce.
Prerequisites
PHYS 101 module 1 (transport, membranes, membrane potential) and PATH 201 module 1 (cell injury and inflammation), because a drug's toxicity is understood as a cell injury and its action as a molecular event at a membrane protein.
The big idea
Every drug prescription is a prediction. 'Take this drug at this dose and it will produce that effect with this risk.' Pharmacology is the discipline that makes that prediction reliable: it tells you where the drug acts, how it reaches that site, how fast it acts, how long it lasts, and what else happens on the way. A clinician who can reason through a drug's action and its disposition does not have to memorise a toxicity — it follows from the mechanism.
Drugs and receptors
Most drug effects begin with a drug binding to a target molecule — almost always a protein. The target is usually a receptor, but targets also include enzymes, ion channels, transporter molecules, and in the case of the anticancer and antibiotic drugs, structural features unique to the target cell. The crucial consequence of this: a drug does not have a pharmacological identity of its own. Its effect is determined by the receptor it binds and by which tissue expresses that receptor.
| Receptor family | Mechanism | Example |
|---|---|---|
| Ligand-gated ion channel | Binding opens a pore, changing the membrane potential directly | The nicotinic acetylcholine receptor at the neuromuscular junction |
| G-protein-coupled receptor | Binding activates a pathway through a G-protein and a second messenger | The beta-adrenoceptor, raising cyclic AMP in cardiac muscle |
| Enzyme-linked receptor | Binding either activates an intrinsic enzyme activity or recruits one | The insulin receptor, a receptor tyrosine kinase |
| Intracellular (nuclear) receptor | The ligand crosses the cell membrane and binds a receptor that regulates transcription | The steroid hormone receptors for cortisol, oestrogen and vitamin D |
Put the receptor distribution and the receptor together, and the whole drug profile falls out. A drug that stimulates beta-two adrenoceptors dilates the bronchi but also causes tremor in skeletal muscle, because both tissues express that receptor. A drug that stimulates muscarinic receptors increases gut motility, salivation and bronchial smooth muscle tone, and slows the heart — because all of these are cholinergically innervated tissues. The side-effect profile is not a list to memorise; it is a map of the receptor's organs.
Worked example: the receptor determines everything
Consider a drug that blocks the beta-adrenoceptor. In a patient with angina it reduces heart rate and contractility, lowering myocardial oxygen demand, and the same action relieves tremor in an anxious patient. But in a patient with asthma, the same drug may block the beta-two receptors in the airways, removing the bronchodilator drive and worsening the wheeze. And in an insulin-dependent diabetic it blocks a limb of the sympathetic response to hypoglycaemia, masking the warning tremor and tachycardia that tell the patient to eat.
Nothing about the drug changed between the three patients. The receptor is in every one of them; the clinical context differs, and so the effect is therapeutic in one and harmful in another. This is the single most useful habit of thinking in pharmacology: predict the effect from the receptor, then ask what else that receptor is doing in a patient who happens to also have other conditions.
A drug blocks the beta-one adrenoceptor. Predict three clinical effects and state where the receptor is located.
Common mistakes
Watch outSaying a drug has one predetermined effect. The effect is a property of the receptor and the tissue. The same molecule is a therapeutic in one patient and a hazard in another, and the profile follows the receptor's distribution.
Watch outTreating antibiotics as an exception in which the target is the organism. The target is still a protein in a cell — the bacterial cell wall, the ribosome, the DNA gyrase — and it is the difference between that bacterial protein and the human equivalent that makes the drug selective.
Watch outSaying a receptor is a molecule inside the cell only. Many are membrane proteins, and the four receptor families differ in whether their ligand can cross the membrane — which is what decides whether an intracellular receptor is used.
Check your understanding
What are the two halves of pharmacology, and why is each necessary?
Name the four receptor families in pharmacology.
Where do the side effects of a beta-blocker come from, mechanistically?
Multiple choice
Which receptor family has the fastest response, and why?
A patient with asthma is given a non-selective beta-blocker for palpitations and wheezes. What is the mechanism?
Which of these is the correct reason for a drug's selectivity between bacterial and human cells?
Which statement about receptor-mediated drug effects is correct?
Where do the cardiovascular effects of a non-selective beta-blocker arise?
Summary and next
Pharmacology has two inseparable halves: pharmacodynamics, what the drug does to the body, and pharmacokinetics, what the body does to the drug. Almost every drug acts by binding a target protein — most often a receptor of one of the four families — and the effect is determined not by the drug but by which receptor, in which tissue. That principle means a drug's entire side-effect profile can be derived from the receptor's distribution, which is the first of the habits of thinking this course builds.
Next: pharmacodynamics proper — agonists, partial agonists, antagonists, the dose-response curve and the therapeutic index, and why a drug that occupies a receptor does not necessarily do what its natural transmitter does.